SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-015861
Filing Date
2023-03-03
Accepted
2023-03-03 17:52:47
Documents
2
Period of Report
2023-03-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1524
2 EX-24 DOCUMENT attachment1.htm EX-24 2316
  Complete submission text file 0001209191-23-015861.txt   5212
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Issuer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PRAXIS PRECISION MEDICINES, INC. 99 HIGH STREET, 30TH FLOOR BOSTON MA 02110
Business Address
DeSimone Jill (Reporting) CIK: 0001930479 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39743 | Film No.: 23706303